Living in the Age of the Jerk: Technology Innovation, Pandemics and our Future Join the Debate

Living in the Age of the Jerk: Technology Innovation, Pandemics and our Future Join the Debate


Members save with free shipping everyday! 
See details


Before Covid-19, humanity was heading towards two doors. Behind one door stood the opportunity to create the closest thing to utopia that has ever existed. Behind the other was a path paved with the threat of growing inequality, eroding privacy, authoritarianism, conflict, and then, at the end, stood dystopia. The great pandemic of 2020 has brought both these doors much closer.

Technology is mutating and nothing in our evolution has prepared us for the changes that are set to follow. It is accelerating at an accelerating rate (in other words, it is experiencing a jerk).

This is not some distant future we are predicting. The change has begun and already we are seeing political division, extremism and social unrest. Strap yourself in because the current political and economic turmoil is nothing compared to what the next two decades will bring.

Technology will enable these changes during the lifetime of most readers of this book.

The consequences are terrifying yet wonderful, for not since we discovered agriculture and moved from hunting to farming have we witnessed so much change.

We can emerge from the technology change that is occurring triumphant, basking in the glory that is human civilisation. We can enjoy a kind of utopia, but we risk, too easily, to descend into a totalitarian disaster.

Living In The Age of The Jerk is for those who care. It is for people who care about their future or the future of their children and grandchildren. It is a book about extraordinary opportunity; it is a book about danger.

If you want to see opportunity triumph over defeat, hope over despair then join the debate.

Product Details

ISBN-13: 9781838040901
Publisher: Techopia
Publication date: 07/14/2020
Pages: 348
Product dimensions: 6.69(w) x 9.61(h) x 0.72(d)

About the Author

With a forward-thinking mindset, Michael started his first business, Solution PR, which specialized in the United Kingdom's computer industry at twenty-four years of age. His groundbreaking career path took him to a full-time investor which projected him as a renowned tech and economics journalist.

Being especially interested in where technology and economics converge, Michael is an avid reader and enthusiast on the topic and writes innumerous articles for respected media channels as, and Motley Fool. He is also a keynote speaker and a reoccurring tv and podcast guest. Michael was the pioneer Editor for Information Age and owned, edited, and published Investment and Business News.

Michael is the co-author of the books iDisrupted and the Blindfolded Masochist, and you can review his other works at Future Everything. Micheal will be soon launching a magazine aimed at the C-Suite called Intelligent Automation and Data Insights along with publishing his third book, Living In The Age of The Jerk.

Julien is the CEO and co-founder of Galen Growth, the leading HealthTech intelligence, analytics, and matchmaking firm serving Fortune 500 companies and institutional investors. Julien is a change catalyst and evangelist who challenges the status quo in healthcare with his deep understanding of the world in which healthcare providers and organizations function. His passion and knowledge around profound technological innovation in transforming healthcare enable the necessary impetus for embracing the trend in the delivery of optimal patient care and health outcomes.

With over 15 years of experience in healthcare with leading brands including Lilly, Boston Scientific, Baxter, GSK, and Merck & Co, Julien has a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. He has gained extensive international business experience across Europe, the Middle East, and Asia.

In 2012, he founded The Propell Group (TPG), a boutique venture investor firm based in Singapore, which focuses on HealthTech startups and growth companies. Since 2012, TPG has invested in 23 companies, including four successful exits.

Customer Reviews